Media Summary: On May 28th, Dr. McCurdy answered the following questions in a very informative Hosted by Drs. Loftus and Ha, and pharmacy specialist Dr. Bhat. Download the resources + collect credit ... Updated March 2021. Having to change any kind of medication can be very stressful. Both

Biosimilars For Ibd Making The Transition Webinar - Detailed Analysis & Overview

On May 28th, Dr. McCurdy answered the following questions in a very informative Hosted by Drs. Loftus and Ha, and pharmacy specialist Dr. Bhat. Download the resources + collect credit ... Updated March 2021. Having to change any kind of medication can be very stressful. Both Regulatory, patient, and provider, United States health care leaders join Earn CME for related activities: This Key Insights™ activity featuring Drs. Marla Dubinsky and ... Hosted by Drs. Edward Loftus, Shubha Bhat, and Christina Ha. Download the resources + credit information ...

While not yet available in the U.S., the Food and Drug Administration recently announced its approval of a Earn CME for related activities: In this presentation from the 'Advances in Dr. Hilary Michel and members of our National Council of College Leaders answer questions about about

Photo Gallery

Biosimilars for IBD: Making the Transition Webinar
Understanding biosimilars: what IBD patients & caregivers need to know
New Title Suggestion: Biosimilars for IBD: When to Switch and What to Ask Your Doctor
Incorporating IBD Biosimilars into Practice: Patient Care and Education
The Current Landscape of Biosimilars in IBD
IBD Clinical Case: The Process of Switching from a Reference Biologic to a Biosimilar
Making the Switch from Biologics to Biosimilars in IBD: Knowledge Over Skepticism
Understanding Biosimilars - For IBD Patients
IBD: Switching from a Biologic to a Biosimilar
Biosimilars in IBD Treatment: Expert Panel Discussion | IBD Pro
Transitioning from Pediatric to Adult Inflammatory Bowel Disease Webinar
Biosimilars 101: An Educational Webinar in Biosimilars
Sponsored
Sponsored
View Detailed Profile
Biosimilars for IBD: Making the Transition Webinar

Biosimilars for IBD: Making the Transition Webinar

On May 28th, Dr. McCurdy answered the following questions in a very informative

Understanding biosimilars: what IBD patients & caregivers need to know

Understanding biosimilars: what IBD patients & caregivers need to know

Have you heard of

Sponsored
New Title Suggestion: Biosimilars for IBD: When to Switch and What to Ask Your Doctor

New Title Suggestion: Biosimilars for IBD: When to Switch and What to Ask Your Doctor

Thinking about switching to a

Incorporating IBD Biosimilars into Practice: Patient Care and Education

Incorporating IBD Biosimilars into Practice: Patient Care and Education

Earn CME for related activities: https://www.naccme.com/ias In this

The Current Landscape of Biosimilars in IBD

The Current Landscape of Biosimilars in IBD

Earn CME for related activities: https://www.naccme.com/ias In this

Sponsored
IBD Clinical Case: The Process of Switching from a Reference Biologic to a Biosimilar

IBD Clinical Case: The Process of Switching from a Reference Biologic to a Biosimilar

Earn CME for related activities: https://www.naccme.com/ias In this

Making the Switch from Biologics to Biosimilars in IBD: Knowledge Over Skepticism

Making the Switch from Biologics to Biosimilars in IBD: Knowledge Over Skepticism

Hosted by Drs. Loftus and Ha, and pharmacy specialist Dr. Bhat. Download the resources + collect credit ...

Understanding Biosimilars - For IBD Patients

Understanding Biosimilars - For IBD Patients

Key things

IBD: Switching from a Biologic to a Biosimilar

IBD: Switching from a Biologic to a Biosimilar

Updated March 2021. Having to change any kind of medication can be very stressful. Both

Biosimilars in IBD Treatment: Expert Panel Discussion | IBD Pro

Biosimilars in IBD Treatment: Expert Panel Discussion | IBD Pro

Discover the Future of

Transitioning from Pediatric to Adult Inflammatory Bowel Disease Webinar

Transitioning from Pediatric to Adult Inflammatory Bowel Disease Webinar

Learn about

Biosimilars 101: An Educational Webinar in Biosimilars

Biosimilars 101: An Educational Webinar in Biosimilars

Regulatory, patient, and provider, United States health care leaders join

Key Insights: Biosimilars and Novel Targets in IBD

Key Insights: Biosimilars and Novel Targets in IBD

Earn CME for related activities: https://www.naccme.com/gastro This Key Insights™ activity featuring Drs. Marla Dubinsky and ...

Making the Switch from Biologics to Biosimilars in IBD: Knowledge Over Skepticism

Making the Switch from Biologics to Biosimilars in IBD: Knowledge Over Skepticism

Hosted by Drs. Edward Loftus, Shubha Bhat, and Christina Ha. Download the resources + credit information ...

Biosimilars and Inflammatory Bowel Disease

Biosimilars and Inflammatory Bowel Disease

Watch this video to learn more about

Why IBD Patients Should Know About Biosimilars

Why IBD Patients Should Know About Biosimilars

While not yet available in the U.S., the Food and Drug Administration recently announced its approval of a

Biosimilars for IBD: Start, Switch, or Stay Away?

Biosimilars for IBD: Start, Switch, or Stay Away?

Earn CME for related activities: https://www.naccme.com/gastro In this presentation from the 'Advances in

Biosimilars for IBD: To Start, Switch, or Stay Away?

Biosimilars for IBD: To Start, Switch, or Stay Away?

Earn CME for related activities: https://www.naccme.com/gastro In this presentation from the 'Advances in

Optimizing Biosimilars for Safe and Effective Management of IMIDs

Optimizing Biosimilars for Safe and Effective Management of IMIDs

Earn CME for related activities: https://www.naccme.com/ias In this

Transitioning through the stages of IBD care: Tips for teens and young adults

Transitioning through the stages of IBD care: Tips for teens and young adults

Dr. Hilary Michel and members of our National Council of College Leaders answer questions about about